Product Code: ETC13319694 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Glucagon Market was valued at USD 2.3 Billion in 2024 and is expected to reach USD 3.37 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global Glucagon Market is experiencing significant growth driven by increasing prevalence of diabetes, rising awareness about hypoglycemia management, and advancements in drug delivery techniques. Glucagon, a hormone used to treat severe hypoglycemia, is witnessing high demand from both diabetic patients and healthcare professionals. The market is characterized by key players such as Eli Lilly and Company, Novo Nordisk A/S, and Xeris Pharmaceuticals, who are investing in research and development to introduce innovative glucagon products. The market is also expanding due to the growing adoption of glucagon emergency kits and technological advancements in glucagon delivery devices. With the increasing focus on diabetes management and improved healthcare infrastructure globally, the Global Glucagon Market is expected to continue its growth trajectory in the coming years.
The Global Glucagon Market is witnessing a surge in demand due to the rising prevalence of diabetes and increasing awareness about hypoglycemia management. The market is experiencing a shift towards innovative delivery devices such as prefilled syringes and nasal sprays, offering convenience and ease of use for patients. Additionally, advancements in glucagon formulations, such as stable liquid formulations and ready-to-use devices, are enhancing patient compliance and driving market growth. Opportunities exist for market players to focus on developing novel glucagon products with improved efficacy and rapid onset of action, catering to the unmet needs of patients. Expansion in emerging markets, collaborations with healthcare providers for better distribution networks, and strategic partnerships for product development are key strategies for companies to capitalize on the growing demand in the Global Glucagon Market.
The Global Glucagon Market faces several challenges, including limited awareness among healthcare professionals and patients about the benefits of glucagon for treating severe hypoglycemia. Additionally, the high cost of glucagon products and the need for specialized training to administer the medication correctly are barriers to its widespread adoption. Regulatory hurdles and the lack of standardized guidelines for glucagon use further complicate market dynamics. Moreover, competition from alternative treatments and the availability of newer, more convenient delivery methods pose challenges to the market growth. Overcoming these obstacles will require increased education and awareness efforts, cost-effective pricing strategies, improved access to training resources, and collaboration among key stakeholders in the healthcare industry.
The Global Glucagon Market is primarily driven by the increasing prevalence of diabetes worldwide, as glucagon is commonly used as an emergency treatment for severe hypoglycemia in diabetic patients. Additionally, the rising awareness about the importance of early intervention in managing hypoglycemia and the growing adoption of advanced diabetes management technologies are fueling the demand for glucagon products. Moreover, the development of novel formulations and delivery methods for glucagon, such as nasal sprays and pre-filled syringes, is expected to drive market growth further. Furthermore, the increasing research and development activities focused on expanding the applications of glucagon in other medical conditions, such as obesity and hypotension, are likely to create new opportunities for market expansion in the coming years.
Government policies related to the Global Glucagon Market primarily focus on regulation, approval, and reimbursement of glucagon products. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in ensuring the safety, efficacy, and quality of glucagon products before they can be marketed. These agencies set guidelines for clinical trials, manufacturing practices, labeling requirements, and post-market surveillance. Additionally, government healthcare systems often determine the reimbursement and pricing of glucagon products, impacting market access and affordability for patients. Policies may also address issues such as intellectual property rights, import/export regulations, and pharmacovigilance to safeguard public health. Overall, government policies are instrumental in shaping the landscape of the Global Glucagon Market by balancing innovation, patient safety, and market dynamics.
The Global Glucagon Market is expected to witness significant growth in the coming years due to the increasing prevalence of diabetes and hypoglycemia cases worldwide. The rising awareness about the importance of glucagon in managing these conditions, coupled with advancements in drug delivery systems, is likely to drive market expansion. Additionally, the development of novel formulations such as nasal sprays and prefilled syringes for glucagon administration is anticipated to boost market growth further. Moreover, collaborations between pharmaceutical companies for the development of innovative glucagon products and increasing research and development activities in this field are expected to contribute to the market`s positive outlook. Overall, the Global Glucagon Market is poised for substantial growth in the foreseeable future.
The global glucagon market is expected to witness significant growth across all regions, with North America leading the market due to the high prevalence of diabetes and increasing adoption of advanced healthcare technologies. Europe follows closely behind, driven by the growing awareness about diabetes management and the presence of key players in the region. In Asia, the market is projected to experience rapid growth attributed to the rising diabetic population and increasing healthcare expenditure. The Middle East and Africa region is also anticipated to contribute to the market growth, supported by improving healthcare infrastructure and rising healthcare investments. Latin America is expected to showcase steady growth due to the increasing focus on diabetes management and the introduction of innovative glucagon products in the region.
Global Glucagon Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Glucagon Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Glucagon Market Revenues & Volume, 2021 & 2031F |
3.3 Global Glucagon Market - Industry Life Cycle |
3.4 Global Glucagon Market - Porter's Five Forces |
3.5 Global Glucagon Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Glucagon Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Glucagon Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Glucagon Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Glucagon Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Glucagon Market Trends |
6 Global Glucagon Market, 2021 - 2031 |
6.1 Global Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Glucagon Market, Revenues & Volume, By Injectable Glucagon, 2021 - 2031 |
6.1.3 Global Glucagon Market, Revenues & Volume, By Nasal Glucagon, 2021 - 2031 |
6.2 Global Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Glucagon Market, Revenues & Volume, By Hypoglycemia, 2021 - 2031 |
6.2.3 Global Glucagon Market, Revenues & Volume, By Diagnostic Aid, 2021 - 2031 |
6.3 Global Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Glucagon Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.3.3 Global Glucagon Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 Global Glucagon Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
7 North America Glucagon Market, Overview & Analysis |
7.1 North America Glucagon Market Revenues & Volume, 2021 - 2031 |
7.2 North America Glucagon Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Glucagon Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Glucagon Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Glucagon Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Glucagon Market, Overview & Analysis |
8.1 Latin America (LATAM) Glucagon Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Glucagon Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Glucagon Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Glucagon Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Glucagon Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Glucagon Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Glucagon Market, Overview & Analysis |
9.1 Asia Glucagon Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Glucagon Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Glucagon Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Glucagon Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Glucagon Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Glucagon Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Glucagon Market, Overview & Analysis |
10.1 Africa Glucagon Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Glucagon Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Glucagon Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Glucagon Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Glucagon Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Glucagon Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Glucagon Market, Overview & Analysis |
11.1 Europe Glucagon Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Glucagon Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Glucagon Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Glucagon Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Glucagon Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Glucagon Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Glucagon Market, Overview & Analysis |
12.1 Middle East Glucagon Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Glucagon Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Glucagon Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Glucagon Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Glucagon Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Glucagon Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Glucagon Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Glucagon Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Glucagon Market Key Performance Indicators |
14 Global Glucagon Market - Export/Import By Countries Assessment |
15 Global Glucagon Market - Opportunity Assessment |
15.1 Global Glucagon Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Glucagon Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Glucagon Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Glucagon Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Glucagon Market - Competitive Landscape |
16.1 Global Glucagon Market Revenue Share, By Companies, 2024 |
16.2 Global Glucagon Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |